--- title: "Advisory Board, Definition | MedTech Terms" description: "Convening of external experts to advise on strategy or product. Plain-English Commercialization definition for MedTech teams, with examples and related terms." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/advisory-board#term", "name": "Advisory Board", "description": "MedTech advisory boards bring together clinicians, scientists, and other experts to advise on product development, clinical strategy, market access, and commercial execution. Subject to Sunshine Act reporting and AdvaMed Code constraints.", "url": "https://medtechterms.com/terms/advisory-board", "termCode": "advisory-board", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/advisory-board#article", "headline": "Advisory Board", "description": "Convening of external experts to advise on strategy or product.", "url": "https://medtechterms.com/terms/advisory-board", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/advisory-board" }, "about": { "@id": "https://medtechterms.com/terms/advisory-board#term" }, "articleSection": "Commercialization", "inLanguage": "en", "keywords": "Advisory Board, Commercialization, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "AdvaMed Code of Ethics", "url": "https://www.advamed.org/our-work/code-of-ethics/", "publisher": { "@type": "Organization", "name": "AdvaMed" } }, { "@type": "CreativeWork", "name": "AHRMM - Healthcare Supply Chain", "url": "https://www.ahrmm.org/", "publisher": { "@type": "Organization", "name": "AHRMM" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/kol#term", "name": "Key Opinion Leader", "alternateName": "KOL", "url": "https://medtechterms.com/terms/kol" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/sunshine-act#term", "name": "Physician Payments Sunshine Act", "url": "https://medtechterms.com/terms/sunshine-act" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Commercialization", "item": "https://medtechterms.com/terms?cat=Commercialization" }, { "@type": "ListItem", "position": 4, "name": "Advisory Board", "item": "https://medtechterms.com/terms/advisory-board" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/advisory-board#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary regulatory concern regarding MedTech advisory boards?", "acceptedAnswer": { "@type": "Answer", "text": "The primary regulatory concern revolves around ensuring that advisory boards are legitimate activities for gathering expert advice and not disguised remuneration for past or future business, which could violate anti-kickback statutes." } }, { "@type": "Question", "name": "How does the Physician Payments Sunshine Act affect MedTech advisory boards?", "acceptedAnswer": { "@type": "Answer", "text": "The Physician Payments Sunshine Act 42 CFR Part 403, Subpart I requires manufacturers of covered drugs, devices, and biologics to report payments and transfers of value made to physicians and teaching hospitals, including compensation for advisory board services." } }, { "@type": "Question", "name": "Are there specific requirements for documenting advisory board activities?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, it is crucial to maintain detailed documentation of the advisory board's purpose, agenda, attendees, minutes, and fair market value compensation rationale, demonstrating legitimacy and transparency to regulators." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Commercialization](/terms?cat=Commercialization) 6. / 7. Advisory Board [All terms](/terms) Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) # Advisory Board Convening of external experts to advise on strategy or product. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition MedTech advisory boards bring together clinicians, scientists, and other experts to advise on product development, clinical strategy, market access, and commercial execution. Subject to Sunshine Act reporting and [AdvaMed](/terms/advamed) Code constraints. What the regulation says Advisory boards, when structured to gather expert opinions on product development or clinical strategies, are generally considered permissible by regulatory bodies like the FDA, provided they adhere to anti-kickback statutes and fair market value compensation guidelines. The [AdvaMed Code of Ethics](/terms/advamed-code), though not a regulation, outlines industry best practices for engagements with healthcare professionals, emphasizing legitimate purpose and transparent interactions to avoid perceptions of improper influence. ## What this means in practice Must be structured around legitimate need, fair-market-value compensation, and documented agendas to avoid anti-kickback risk. ## Examples - A MedTech company convenes an advisory board of cardiologists to provide input on the design and clinical testing protocol for a new cardiac stent, ensuring the board’s purpose is clearly defined and documented. - A medical device manufacturer meticulously tracks and reports all compensation paid to physician advisory board members to comply with the Physician Payments Sunshine Act 42 CFR Part 403, Subpart I reporting requirements. - Before launching a new surgical robot, a company forms an advisory board of orthopedic surgeons to discuss optimal surgical workflows and user interface improvements, with all interactions transparently recorded. Common pitfalls - • Improperly compensated advisory board members can pose a significant anti-kickback risk, leading to potential legal and financial penalties. - • Advisory boards lacking a clear, documented purpose or agenda may be viewed as a disguised inducement, rather than a legitimate scientific or business activity. - • Failing to report advisory board compensation and participants as required by regulations such as the Physician Payments Sunshine Act 42 CFR Part 403, Subpart I can result in fines and reputational damage. - • Advisory boards composed exclusively of individuals with pre-existing commercial interests, lacking diverse and independent expert perspectives, can undermine credibility. - • Using an advisory board as a sales channel, rather than a genuine forum for expert feedback, can lead to compliance violations and ethical breaches. ## Frequently asked questions What is the primary regulatory concern regarding MedTech advisory boards? The primary regulatory concern revolves around ensuring that advisory boards are legitimate activities for gathering expert advice and not disguised remuneration for past or future business, which could violate anti-kickback statutes. How does the Physician Payments Sunshine Act affect MedTech advisory boards? Are there specific requirements for documenting advisory board activities? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Commercialization Key Opinion Leader(KOL) Influential clinician who shapes peer practice and adoption. ](/terms/kol)[ Commercialization Physician Payments Sunshine Act U.S. law requiring disclosure of payments to physicians and teaching hospitals. ](/terms/sunshine-act) ### More in Commercialization · Same category [ Commercialization AdvaMed Code of Ethics Industry code governing interactions between U.S. medical-device companies and healthcare professionals. ](/terms/advamed-code)[ Commercialization Anti-Kickback Statute(AKS) U.S. criminal statute prohibiting remuneration to induce federal healthcare business. ](/terms/anti-kickback)[ Commercialization Bottom-Up Market Sizing Building market size from procedure volumes × price × penetration. ](/terms/bottom-up-sizing)[ Commercialization Distributor vs Direct Sales Choice between selling through third-party distributors or hiring a direct salesforce. ](/terms/distributor-direct) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) ## Primary references 2 sources Link health: 2 verified · last checked 2026-06-20 AdvaMed· 1 AHRMM· 1 1. [1 AdvaMed Code of Ethics Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/code-of-ethics/) 2. [2 AHRMM - Healthcare Supply Chain Verified AHRMM · ahrmm.org ](https://www.ahrmm.org/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Selling a connected device into health systems? Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Commercialization Sources 2 Updated 5/5/2026 [Compare with another term](/compare?a=advisory-board) Learn in 60 seconds Card Lesson Quiz Convening of external experts to advise on strategy or product. - · Must be structured around legitimate need, fair-market-value compensation, and documented agendas to avoid anti-kickback risk. - · Subject to Sunshine Act reporting and AdvaMed Code constraints. Remember this Watch out: Improperly compensated advisory board members can pose a significant anti-kickback risk, leading to potential legal and financial penalties. Related terms - [Key Opinion Leader(KOL) ](/terms/kol) - [Physician Payments Sunshine Act ](/terms/sunshine-act) You may also need Auto-suggested from Commercialization and shared keywords. - [Specialty MedTech Venture Capital ](/terms/specialty-medtech-vc) - [AdvaMed Code of Ethics ](/terms/advamed-code) - [Value Analysis Committee(VAC) ](/terms/vac) - [Fogarty Innovation ](/terms/fogarty-innovation) - [Good Clinical Practice(GCP) ](/terms/gcp) - [Launch Readiness ](/terms/launch-readiness) [All Commercialization terms](/terms?cat=Commercialization) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)